CITRA ANTICOAGULANTS, INC. - PRWeb Press Release Account Feed http://www.rsspad.com/rss2a/66631.xml CITRA ANTICOAGULANTS, INC. - Press Releases en xml@emediawire.com xml@emediawire.com 30 Citra Anticoagulants Signs Distribution Agreement for LOXXIT™ Catheter Lock Solution with L.IN.C-Medical Systems LTD http://www.prweb.com/releases/2007/12/prweb594401.htm Citra Anticoagulants, Inc. reported that they signed a distribution agreement with L.IN.C-Medical Systems Ltd to distribute LOXXIT™ Catheter Lock Solution in the United Kingdom and Ireland. (PRWeb Dec 30, 2007)

Read the full story at http://www.prweb.com/releases/2007/12/prweb594401.htm

]]> http://www.prweb.com/releases/2007/12/prweb594401.htm Citra Anticoagulants Signs Exclusive Distribution Agreement with HAEMO-Pro for LOXXIT™ Catheter Lock Solution http://www.prweb.com/releases/2007/10/prweb560709.htm Citra Anticoagulants, Inc. reported that they signed a distribution agreement with HAEMO-Pro to distribute LOXXIT™ Catheter Lock Solution in Germany. (PRWeb Oct 13, 2007)

Read the full story at http://www.prweb.com/releases/2007/10/prweb560709.htm

]]> http://www.prweb.com/releases/2007/10/prweb560709.htm Citra Anticoagulants Announces CE Mark Approval for LOXXIT™ Catheter Lock Solution http://www.prweb.com/releases/2007/09/prweb554748.htm Citra Anticoagulants, Inc. a worldwide distributor of citrate-based anticoagulants received CE Mark approval for LOXXIT™ Catheter Lock Solution. (PRWeb Sep 20, 2007)

Read the full story at http://www.prweb.com/releases/2007/09/prweb554748.htm

]]> http://www.prweb.com/releases/2007/09/prweb554748.htm Citra Anticoagulants, Inc. and H.A.C. Pharma Sign Marketing Agreement For Promotion Of LOXXIT™ Catheter Lock Solution To The EMEA Market http://www.prweb.com/releases/2007/09/prweb554767.htm Citra Anticoagulants, Inc. a worldwide distributor of citrate-based anticoagulants reported that it has signed a Marketing Services Agreement with H.A.C. Pharma for LOXXIT™ Catheter Lock Solution. (PRWeb Sep 20, 2007)

Read the full story at http://www.prweb.com/releases/2007/09/prweb554767.htm

]]> http://www.prweb.com/releases/2007/09/prweb554767.htm Citra Anticoagulants Announces CE Mark Approval for noClot-400™ Anticoagulant Citrate Dextrose Solution, Solution A, ACD-A, U.S.P., 4 Milliliters http://www.prweb.com/releases/2007/02/prweb502306.htm Citra Anticoagulants, Inc. announces that noClot-400™ Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., 4 milliliters known as ACD-A, has CE mark approval for use in the extracorporeal blood processing with Autologous Platelet Rich Plasma (PRP) Systems in the production of platelet rich plasma. (PRWeb Feb 4, 2007)

Read the full story at http://www.prweb.com/releases/2007/02/prweb502306.htm

]]> http://www.prweb.com/releases/2007/02/prweb502306.htm Citra Anticoagulants Announces FDA Approval for NO CLOT-50™, ACD-A http://www.prweb.com/releases/2004/11/prweb181730.htm Citra Anticoagulants Announces FDA Approval to Market NO CLOT-50™ Anticoagulant Citrate Dextrose Solution, Solution A, ACD-A (PRWeb Nov 23, 2004)

Read the full story at http://www.prweb.com/releases/2004/11/prweb181730.htm

]]> http://www.prweb.com/releases/2004/11/prweb181730.htm CYTOSOL LABORATORIES RECEIVES FDA APPROVAL TO MARKET TRICITRASOL® ANTICOAGULANT SODIUM CITRATE CONCENTRATE http://www.prweb.com/releases/2003/07/prweb72710.htm Cytosol Laboratories, Inc. announces it has received U.S. Food and Drug Administration (FDA) approval for TRICITRASOL® Anticoagulant Sodium Citrate Concentrate, 46.7% Sodium Citrate, for use in granulocytapheresis. TRICITRASOL is the critical, citrate-based anticoagulant used in the collection of granulocytes from normal, blood donors. The harvested granulocytes are used in the treatment of cancer patients. (PRWeb Jul 17, 2003)

Read the full story at http://www.prweb.com/releases/2003/07/prweb72710.htm

]]> http://www.prweb.com/releases/2003/07/prweb72710.htm